News

FOXFIRE Combined Analysis

FOXFIRE Combined Analysis indicates no benefit in overall survival from adding selective internal radiotherapy [SIRT] to first-line oxaliplatin-based chemotherapy for metastatic colorectal cancer.

Secondary analyses confirm improved control of liver metastases with liver-directed SIRT and show clinical benefit in patients with liver metastases originating from difficult-to-treat right-sided colon cancer.

100km non-stop in 24 hours

Five members of Professor Len Seymour's laboratory (Arthur Dyer, Sally Frost, Sophie Owen, Tzveta Pokrovska and Ellie Scott) are limbering up to walk 100km non-stop in 24 hours over the August bank holiday to raise money for Cancer Research UK, Martlet's Hospice and the Red Cross.

If you have any spare money and would like to support them please visit the Just Giving page – all donations are greatly appreciated. 

In advance of any donations received the “Angels” thank you for your support.

Cancer Research UK Boat Race

Joshua Bugajski (Stroke 4), an MSc Oncology student in Katherine Vallis’ group was part of Oxford’s winning team on Sunday, 2 April when they cruised to victory in the 2017 Cancer Research UK boat race against Cambridge. 

Oxford won the toss and chose the Surrey station.  The crew took an early lead over Cambridge and this was Oxford’s 80th win in the event’s history – just 2 behind their rivals. 

(photo credited to Getty Images)

 

2016 Oxford Harrington Scholarship

It was announced in August 2016 that Professor Valentine Macaulay was awarded the 2016 Oxford Harrington Scholarship. Professor Macaulay’s work focuses on understanding growth factor receptor function, and the award was given to support novel approaches to disrupt receptor function as therapy for cancer.  "I am honoured to be selected as the 2016 Oxford Harrington Scholar" said Professor Macaulay, "and I will do my utmost to exploit the opportunities provided by this award.".

New era in precision medicine for pancreatic cancer

The development of new treatments for pancreatic cancer is set to be transformed by a network of pancreatic clinical trials, aiming to find the right trial for the right patient, after a £10 million investment from Cancer Research UK announced today.

The investment will support the PRECISION Panc project which aims to develop personalised treatments for pancreatic cancer patients, improving the options and outcomes for a disease where survival rates have remained stubbornly low.

2016 Advanced Apprenticeship Award

Workshop Apprentice Kyle Hallett, has been awarded the 2016 Advanced Apprentice Award at the University of Oxford’s 2016 Apprenticeship Awards which was held at the Sheldonian on Friday, 9 December.  The award has recognised Kyle’s huge amount of enthusiasm for learning all aspects of work.  He has embraced new technologies in advanced design and manufacture and is already providing his worth by increasing the workshop productivity in the Department.   Kyle is in his second year of his appre

Pages

About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
Research
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.
Subscribe to RSS - News